Intellia Thera CS (NTLA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2022 | 06-2022 | 03-2022 | 12-2021 | 09-2021 | |
| Sales | 13,266 | 14,030 | 11,252 | 12,854 | 7,204 |
| Gross Profit | 13,266 | 14,030 | 11,252 | 12,854 | 7,204 |
| Operating Expenses | 118,796 | 112,331 | 155,498 | 93,269 | 79,197 |
| Operating Income | -105,530 | -98,301 | -144,246 | -80,415 | -71,993 |
| Other Income | -7,699 | -2,377 | -2,626 | -822 | 349 |
| Pre-tax Income | -113,229 | -100,678 | -146,872 | -81,237 | -71,644 |
| Net Income Continuous | -113,229 | -100,678 | -146,872 | -81,237 | -71,644 |
| Net Income | $-113,229 | $-100,678 | $-146,872 | $-81,237 | $-71,644 |
| EPS Basic Total Ops | -1.49 | -1.33 | -1.96 | -1.11 | -0.97 |
| EPS Basic Continuous Ops | -1.49 | -1.33 | -1.96 | -1.11 | -0.97 |
| EPS Diluted Total Ops | -1.49 | -1.33 | -1.96 | -1.11 | -0.97 |
| EPS Diluted Continuous Ops | -1.49 | -1.33 | -1.96 | -1.11 | -0.97 |
| EBITDA(a) | $-103,580 | $-96,464 | $-142,492 | $-78,535 | $-70,207 |